 NEWTOWN, PA., March 01, 2021 GLOBE NEWSWIRE -- Onconova Therapeutics, Inc. NASDAQ: ONTX Onconova, a biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that Steven Fruchtman, M.D., President and Chief Executive Officer, will participate in three virtual investment conferences during the month of March, as follows: 